Literature DB >> 27882421

Invasive meningococcal disease-induced myocarditis in critically ill adult patients: initial presentation and long-term outcome.

Thomas Madelaine1,2, Martin Cour1,2, Julien Bohé3, Bernard Floccard4, Serge Duperret5, Romain Hernu1, Laurent Argaud6,7.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27882421     DOI： 10.1007/s00134-016-4623-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Myocarditis in 200 fatal meningococcal infections.

Authors:  J M Hardman; K M Earle
Journal:  Arch Pathol       Date:  1969-03

2.  Myocardial injury in meningococcus-induced purpura fulminans in children.

Authors:  G Briassoulis; M Narlioglou; N Zavras; T Hatzis
Journal:  Intensive Care Med       Date:  2001-06       Impact factor: 17.440

3.  Pathogenesis and diagnosis of human meningococcal disease using immunohistochemical and PCR assays.

Authors:  Jeannette Guarner; Patricia W Greer; Anne Whitney; Wun-Ju Shieh; Marc Fischer; Elizabeth H White; George M Carlone; David S Stephens; Tanja Popovic; Sherif R Zaki
Journal:  Am J Clin Pathol       Date:  2004-11       Impact factor: 2.493

4.  Fatal meningococcal disease in childhood: an autopsy study of 86 cases.

Authors:  U Neveling; R O Kaschula
Journal:  Ann Trop Paediatr       Date:  1993

5.  Histologic pathologies of the myocardium in septic shock: a prospective observational study.

Authors:  Christian A Schmittinger; Martin W Dünser; Christian Torgersen; Günter Luckner; Ingo Lorenz; Stefan Schmid; Michael Joannidis; Patrizia Moser; Walter R Hasibeder; Milo Halabi; Christina M Steger
Journal:  Shock       Date:  2013-04       Impact factor: 3.454
  5 in total
  1 in total

1.  Real-world evidence of quadrivalent meningococcal conjugate vaccine safety in the United States: a systematic review.

Authors:  Tracy A Becerra-Culqui; Lina S Sy; Zendi Solano; Hung Fu Tseng
Journal:  Hum Vaccin Immunother       Date:  2020-12-17       Impact factor: 3.452
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.